Skip to main content
. Author manuscript; available in PMC: 2012 Jan 1.
Published in final edited form as: Inflamm Bowel Dis. 2011 Jan;17(1):221–231. doi: 10.1002/ibd.21359

Table 1. Summary of clinical data for individual disease groups.

N=normal from patients without IBD or colorectal cancer history; N-IBD = normal “unaffected” specimens from IBD patients; IBD =“affected” chronically inflamed specimens from IBD patients; IBD-Dys = dysplastic specimens from IBD patients; IBD-C = cancer specimens from IBD patients; SCRC = sporadic colorectal specimens from patients without any history of IBD.

IBD-C IBD-Dys IBD N-IBD N SCRC
Age 49.4 57.4 46.2 48.8 60.6 68.9
Sex M/F 21/16 6/5 24/11 16/6 12/2 7/8
IBD type
UC/CD/IC		 30/5/2 9/2 24/11/0 15/7/0 N/A N/A
Location
Right/Left		 12/25 5/6 5/30 18/4 26/29 3/12